Varian Strategic Investments

Profile and portfolio

Parent Varian

Varian Strategic Investments is the corporate venture arm of Varian, a healthcare company. It invests from Series B to Series C+. Sectors it names: medical devices, biotech and life sciences.

Every figure links to its source

Snapshot

Investment stage: Series B to Series C+

Data behind this graphic

Data behind this graphic
Item	Value
Stage range	Series B to Series C+
Sectors	Medical devices, Biotech and life sciences
Geography	North America

Sources: S1 HistoSonics closes $54 Million Series C led by Varian (PR Newswire, 2019).

Where it invests

Geography

Investment regionsS1

North America

Key facts

Fact	Value	Status	Source
Parent company	Varian	Single source	S1
Parent industry	Healthcare and life sciences	Single source	S1
Capital source	Parent company only	Single source	S1
Stages	Series B, Series C+ (inferred from announced rounds)	Estimate	S1

Recent rounds

Date	Company	Round	Amount	Led by the firm	Source
2019-04-08	HistoSonics	Series C+	USD 54M	Yes	S1
2019-04-02	Fusion Pharmaceuticals	Series B	USD 105M	Yes	S1

Portfolio

Public sources name 3 portfolio companies.S1

Shared portfolio with other corporate VCs

1 companies on the Varian Strategic Investments portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

Firm	Shared	Companies in common
Sunway iLabs	1	HistoSonics

Companies backed by the most corporate VCs

Every company on the Varian Strategic Investments list

3 companies, as named in the sources cited.S1 Read the firm's list.

COTA Healthcare
Fusion Pharmaceuticals
HistoSonics

Sources

S1HistoSonics closes $54 Million Series C led by Varian (PR Newswire, 2019)Press

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Varian Strategic Investments or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.

Report a correction